Juvenile
rheumatoid arthritis is a childhood disease that causes
inflamed, swollen joints. This makes joints stiff and painful.
Unlike adults with
rheumatoid arthritis, many children with the disease
grow out of it after they get treatment. Others will need ongoing treatment as
adults.
There are three types of juvenile rheumatoid
arthritis.
Pauciarticular is the most common and
mildest type. Your child may have pain in 1 to 4 joints, such as the knees,
ankles, fingers, toes, wrists, elbows, or hips.
Polyarticular is more severe. It affects more joints
and tends to get worse over time.
Systemic is the
least common type. But it can be the most serious. It causes pain in many
joints and can also spread to organs.
What causes juvenile rheumatoid arthritis?
Doctors don't really know what causes the
disease. But there are a number of things that they think can lead to it. These
things include:
An
immune system that is too active and attacks joint
tissues.
Viruses or other infections that cause the immune system
to attack joint tissues.
Having certain
genes that make the immune system more likely to
attack joint tissues.
What are the symptoms?
Children can have one or many symptoms, such as:
Joint pain.
Joint
swelling.
Joint stiffness.
Trouble
sleeping.
Problems walking.
In some cases these symptoms can be mild and hard for you
to see. A young child may be more cranky than normal or may go back to crawling
after he or she has started walking. You may notice that your child feels stiff
in the morning or has trouble walking.
Children with this disease
can also get inflammatory
eye disease. This can lead to permanent vision
problems or blindness if it's not treated. Eye disease often has no symptoms
before vision loss occurs. That's why it's important for your child to have
regular eye exams with an
ophthalmologist. Treatment can begin before your child
has long-lasting vision problems.
How is juvenile rheumatoid arthritis diagnosed?
Your doctor will ask
questions about your child's symptoms and past health and will do a physical
exam. Your child may also have blood tests and a urine test to look for signs
of the disease. If your child has the disease, these tests can help your doctor
find out which type it is.
How is it treated?
Your child's treatment will be
based on the type of arthritis he or she has and how serious it is. The most
common treatment includes medicines to reduce pain and swelling
(NSAIDs), along with
physical therapy. Your child may also get shots of
steroid medicine into a joint to relieve swelling and
pain.
If these treatments don't help, then your child may be given
other medicines. Surgery to correct joint problems is only done in rare
cases.
Exercise is an important part of your child's treatment.
Physical therapists can teach you and your child exercises to keep your child's
muscles flexible and strong. Moving your child's painful joints through their
full range of motion keeps them from getting stiff or deformed. Many children
with the disease don't want to move painful joints. Your child may need your
help to keep doing daily physical therapy.
Even when juvenile
rheumatoid arthritis is not a severe type, your child may still need long-term
treatment. To make sure that treatment is right for your child, work closely
with the medical team. Learn as much as you can about your child's disease and
treatments. Stay on a schedule with your child's medicines and exercise.
How do you cope with juvenile rheumatoid arthritis?
Exercise, medicine, and assistive devices will
help your child get through each day as normally as possible. Assistive devices
are things that can help your child hold onto, open, or close things more
easily. A doorknob extender, used to open a door without twisting a wrist, is
one such device.
Children with this disease need to balance
exercise and rest. They may need extra rest during the day to relax their
joints and keep up their energy. But be sure that your child gets enough
exercise. This will help keep joints strong and flexible.
Pain
relief exercises can help you and your child control joint pain caused by the
disease. Your child's doctor can help you set up a pain management plan. This
plan might include heat treatments, exercise, and a type of counseling called
cognitive-behavioral therapy. Breathing and relaxation
exercises can also help ease your child's pain.
The cause of
juvenile rheumatoid arthritis (JRA) is not well
understood. Most experts believe it is caused by a combination of factors,
including:
An overly active
immune system that inappropriately attacks joint
tissues, as though they were a foreign substance.
Viral or
bacterial infections, which are a suspected trigger of the
autoimmune process.
Genetic factors that make a child's immune system more
likely to react inappropriately. A study of relatives of children with JRA
reported a higher occurrence of other autoimmune diseases in these families. It
is possible that these families share genes that make them more susceptible to
autoimmune diseases, including JRA.1
An increasing number of international experts are now
referring to JRA as juvenile idiopathic arthritis (JIA): idiopathic means "of
unknown cause." As the international terminology becomes more widely used, you
may hear different terms used to describe each type of childhood arthritis. To
learn more about the new international "juvenile idiopathic arthritis"
classification, as compared with the American "juvenile rheumatoid arthritis"
and the European "juvenile chronic arthritis," see
classification.
Joint pain and swelling that may come and go
but are most often persistent.
Joint stiffness in the
morning.
Irritability, refusal to walk, or protection or guarding
of a joint. You might notice your child limping or trying not to use a certain
joint.
Often unpredictable changes in symptoms, from periods with no
symptoms (remission) to flare-ups.
Even though pain is a common symptom of JRA, a child may
not identify pain as a problem. A child may be unable to describe pain or may
become accustomed to the presence of pain. The child may be more alarmed by
symptoms such as stiffness and may be better able to describe those symptoms.
Some researchers believe that some children who have repeated medical
procedures that cause pain may be afraid of further doctor visits and more
anxious about their illness.2 This could cause them to
not express or identify their pain because of fear of medical
procedures.
Eye disease usually
causes no symptoms before permanent vision loss occurs. For this reason, it is
very important for a child with JRA to have eye examinations with an
ophthalmologist to detect developing eye damage so
that treatment can be started before permanent vision problems occur. If
symptoms are present, they may be as mild as painless red eyes, or the symptoms
can include blurred vision, eye pain, sensitivity to light, and vision
loss.
Fever spikes caused by systemic JRA typically reach
103
°F (39.5
°C) to
106
°F (41
°C), one to two times
daily, with a fall to normal between spikes.
Rash caused by
systemic JRA is spotty, flat, and sometimes faint red or pink and may occur
with the fever. It may erupt over the torso, face, palms, soles of feet, and
armpits. The rash often comes and goes and may appear late in the day or in the
early morning. It may also be brought on by warm baths or by rubbing or
scratching the skin.
Other conditions with similar symptoms
to JRA include
growing pains, overuse, injury, bone infection, and
certain inflammatory diseases, among others. Many conditions can cause painful,
stiff joints in children. Most often, occasional joint pain in children is
related to an injury or aggravating factors, such as repetitive overuse in
sports activities. JRA is a relatively uncommon cause of these symptoms.
The course of
juvenile rheumatoid arthritis (JRA) is unpredictable,
especially during the first few years after a child is diagnosed. JRA, also
called juvenile idiopathic arthritis (JIA) or juvenile chronic arthritis (JCA),
can be mild, causing few problems. Symptoms can get worse or disappear without
clear reason. Eventually the pattern of symptoms becomes more predictable. In
general, children with JRA have one or a combination of symptoms including
joint pain, joint swelling, and joint stiffness early in the course of the
disease. Many children experience sleep disturbances, including difficulty
falling asleep and frequent night awakenings.3 Most
children have good and bad days.
Of all children with JRA, 3 or 4
out of 10 children will have long-term disability.4
While the overall long-term outlook for children with JRA is often good,
symptoms of the disease can continue into adulthood. Long-term disability may
range from occasional stiffness, the need for pain medicine, and limits on
physical activity to ongoing arthritis and the need for major surgery such as
joint replacement. But for most adults who had JRA as children, any long-term
problems tend to be mild and do not affect their overall quality of life. For
instance, they may not be able to play certain sports, but their activities are
not otherwise limited.
A child's long-term outlook is influenced
by the type of juvenile rheumatoid arthritis he or she has. While a child with
pauciarticular JRA (4 or fewer joints affected) has a
good long-term outlook other than eye disease risk, a child with
polyarticular JRA (5 or more joints) or
systemic JRA (whole-body symptoms) is likely to have
more long-term problems.5
Pauciarticular JRA (oligoarthritis)
About 40% to
60% of all children affected by JRA have the pauciarticular form.4 Some children with more severe disease have joint damage that
shows on X-rays within 5 years. Children with pauciarticular JRA
(oligoarthritis, meaning "few joints") have a 40% to 50% chance of continuing
to have disease as an adult.4 Among children with
pauciarticular JRA:5
Most children have 4 or fewer joints
affected.
Some go on to have 5 or more joints affected over time
(referred to as extended oligoarthritis, resembling
polyarthritis).
Some children
have uneven leg bone growth, resulting in legs of different length and muscle
wasting.4
Polyarticular JRA (polyarthritis)
Polyarticular
JRA (polyarthritis) affects many joints-often the knee, hip, wrist, elbow, and
ankle joints-and may affect the small joints in the hands and feet. This type
of JRA is more severe than pauciarticular JRA because it affects more joints
and tends to get worse over time. Joint damage can be seen on X-ray within 2
years in children with more severe disease. About 25% to 35% of children
affected by JRA have the polyarticular form. Of these children, about 50% to
70% will have active disease that continues into adulthood.4
For a child with polyarticular JRA, the
following are signs of increased risk of developing joint deformity and
disability as an adult:5
Onset of disease later in
childhood
Joint problems in hands or feet early in the course of
the disease
Rapidly progressing joint damage
Chronic
symptoms that don't respond to treatment
Significant whole-body
(systemic) symptoms, such as fever, fatigue, and appetite
loss
Bumps under the skin (rheumatoid nodules) over pressure points (such as the elbow or back of the
heel)
Of all children with juvenile rheumatoid arthritis, only
about 5% to 10% have polyarticular JRA with the presence of the
rheumatoid factor (RF) antibody in their
blood.4 Normally, antibodies are produced by the
immune system to help destroy and eliminate invading bacteria and viruses that
can cause disease. But RF is an antibody that can attach to normal body tissue,
resulting in damage. RF-positive polyarticular JRA is thought to be identical
to adult
rheumatoid arthritis. The risk of joint deformity is
highest (about 50% likelihood) in children with RF-positive polyarticular
JRA.6
Systemic JRA
About 10% to 20% of children
affected by JRA have the systemic form.4 Usually, a
child with systemic JRA will have fever spikes and a rash for weeks to months
before arthritis joint pain begins. Whole-body (systemic) symptoms (such as
fatigue and loss of appetite) and enlarged lymph nodes, liver, and spleen may
come and go during the first years of the disease. About a third of children
with systemic JRA develop heart and complications.6
Some children with systemic JRA will have joint
damage visible on X-ray within 2 years. About 50% to 70% of children with
systemic JRA will continue to have active disease as adults.4 Systemic symptoms rarely last more than 5 years, while joint
symptoms can last 10 years or more.5
Growth abnormalities, such as unequal leg lengths, an
imbalance in growth of the jaw, and temporary delay in breast
growth.
Joint damage. This is common in the polyarticular form of
JRA and can occur early. About 30% of children with JRA will have some level of
disability that continues into adulthood.7 Children
with the pauciarticular form of JRA seldom develop significant
disabilities.
Some children with polyarthritis develop arthritis in the
neck that can cause the neck bones to fuse together. A child who has arthritis
in the neck may need to wear a neck (cervical) collar when riding in a vehicle
to reduce the risk of neck injury during a sudden stop or accident.
No clear risk factors for
juvenile rheumatoid arthritis (JRA) are known at this
time. But a recent study of relatives of children with JRA reported a higher
occurrence of other
autoimmune diseases in these families. It is possible
that these families share genes that make them more susceptible to autoimmune
diseases, including JRA.1
When To Call a Doctor
Call your doctor immediately if:
Your child has sudden, unexplained swelling,
redness, and pain in any joint or joints.
A baby or child is
unusually cranky or reluctant to crawl or walk.
Red eyes, eye pain,
and vision blurring or loss occur in a child who has been diagnosed with any
form of juvenile arthritis.
Call your doctor if any of the following symptoms continue
for more than 2 days:
A child has unexplained daily fever spikes
[103
°F (39.4
°C) to
106
°F (41.1
°C)] with or without
a pink skin rash.
A baby or child is reluctant to crawl or walk in
the early morning but improves after 1 to 2 hours.
A child taking aspirin or another nonsteroidal
anti-inflammatory drug (NSAID) develops stomach pain not clearly related to
stomach flu, but possibly related to medicine use (symptoms such as heartburn,
nausea, or refusal to eat).
Joint pain and skin rash develop
following a sore throat.
Watchful Waiting
It can be hard to know when an infant has joint
pain. A young child may be unusually cranky or may revert to crawling after he
or she has started walking. You may notice gait problems with a walking child
or stiffness in the morning.
It is reasonable to try home
treatment (hot or cold packs, rest, and acetaminophen) for mild joint pain. If
there is no improvement in 1 to 2 weeks or if any of the other symptoms
described above are present, see a doctor. If redness or swelling is present in
a single joint, or if the pain is severe, call your doctor immediately. This
could indicate an infection in the joint.
For additional testing and disease management, consult
with a
rheumatologist who specializes in children's rheumatic
disease (pediatric rheumatologist).
The disease management team
for JRA may also include:
An
orthopedic surgeon who specializes in children's
orthopedic problems (pediatric
orthopedist).
Nurses.
Physical and occupational
therapists.
A registered dietitian or nutritionist, as
needed.
Findings from a physical examination,
including the pattern and nature of joint symptoms, are important keys to the
diagnosis of
juvenile rheumatoid arthritis (JRA). In most cases,
routine lab results do not point to an obvious diagnosis of this disease. JRA
is often diagnosed only after other possible causes of symptoms have been ruled
out and the pain and stiffness have lasted for at least 6 weeks. The following
tests are mainly done to see whether another medical condition is causing joint
pain or whole-body (systemic) symptoms.
Routine examinations and
tests include the following:
Antinuclear antibody (ANA), to clarify
a child's type of JRA and risk for eye disease (a positive ANA result is a
marker for high eye disease risk, usually found in girls who develop
pauciarticular JRA at a young age)
Human
lymphocyte antigen or HLA-B27 genetic test, which may help distinguish JRA from
other types of arthritis that affect children, such as
ankylosing spondylitis
Early Detection
There are no standard screening tests that are
used to identify children who may develop juvenile rheumatoid arthritis
(JRA).
Early eye disease detection
Slit lamp eye examinations are necessary for all
children with juvenile rheumatoid arthritis to test for possible eye problems,
such as
uveitis. This test may be repeated often during the
course of the condition because the
inflammatory eye disease associated with JRA generally
has no symptoms and can lead to a permanent decrease in vision or
blindness.
Inflammatory eye disease risk is not related to how
severe a child's other JRA symptoms are. In fact, children at greatest risk are
girls who develop mild pauciarticular disease (oligoarthritis) during their
early childhood years and have developed high levels of antinuclear antibodies
(ANAs).
Treatment Overview
The goals of medical treatment for
juvenile rheumatoid arthritis (JRA) are to reduce your
child's joint pain and to prevent disability. Physical therapy and medicine are
the basis of medical treatment for JRA, also called
juvenile idiopathic arthritis (JIA) or juvenile
chronic arthritis.
Treatment is determined by the type and
severity of JRA. Even when JRA is uncomplicated, an affected child still needs
many years of medical treatment. To make sure your child's care is appropriate
for the stage of disease, work closely with the medical team. Learn as much as
you can about your child's disease and treatments, and stay on schedule with
medicine and exercise.
Because pain, stiffness, and swelling can
change from day to day, it is important to learn how to assess your child's
condition. It can be hard to know if children are having pain. Some children
are not able to say what they feel, while others are afraid to say they feel
pain if they think they will have to go to the doctor or think they will make
their parents upset. Children also simply learn to cope with pain by sleeping
or playing. To know a child is in pain, you may need to look for changes such
as stiff movements, rubbing a joint or muscle, or avoiding movement.8 You may also notice your child is irritable or easily
upset.
Initial treatment
Treatment for
juvenile rheumatoid arthritis (JRA) usually begins
after your doctor has eliminated other causes for your child's symptoms. A good
indicator of JRA is if your child's pain, swelling, and stiffness in the joints
have persisted for at least 6 weeks. Your doctor may set up a treatment team,
often including a pediatrician, rheumatologist, and physical and/or
occupational therapist.
Physical exercise is a crucial part of
treatment for a child with JRA. Your child's
physical and
occupational therapists can teach you and your child
exercises to do at home to prevent
contractures and maintain joint range and muscle
strength. Moving your child's arthritic joints regularly through their full
range of motion helps prevent stiffening or deformity.
Many children with JRA don't want to move painful joints and need to be
encouraged to continue with daily physical therapy.
Medicine will
likely be an important factor in your child's treatment.
Unless your child's condition is
life-threatening or involves severe eye or joint inflammation, nonsteroidal
anti-inflammatory drugs (NSAIDs) are likely to be the first line
of medication treatment to reduce inflammation and any pain. If you see no
improvement after 6 weeks, your doctor may try a different NSAID. Some children
gain relief from one NSAID but not another.
In cases of severe
JRA, your doctor may prescribe medicines referred to as
disease-modifying antirheumatic drugs (DMARDs) or
slow-acting antirheumatic drugs (SAARDs). DMARDs/SAARDs that may be prescribed
for JRA include methotrexate, either alone or in combination with other
medicines, and/or a newer DMARD called
etanercept (Enbrel), which is a tumor necrosis factor
(TNF) inhibitor.
A corticosteroid injection into a joint also may
be used to reduce inflammation, particularly if your child has
pauciarticular JRA (oligoarthritis).
Inflammatory eye disease may develop in children with
JRA. Because this form of eye disease generally has no symptoms and can lead to
a permanent decrease in vision or blindness, part of your child's treatment
plan should be regular checkups with an
ophthalmologist. Most children who develop eye disease
are treated with corticosteroids and prescription eyedrops called
mydriatics.9
Home treatment to
help your child function as normally as possible should include and address
activities in the home, school, and community.
Range-of-motion exercises, done twice
daily with the assistance of an adult, will help to maintain joint range and
muscle strength and prevent contractures.
Balancing rest and activity may mean extra naps or quiet times during the day, mixed with
frequent activity to keep muscles from stiffening and
weakening.
Assistive devices can help your child hold onto, open,
close, move, or do things more easily. Doorknob extenders, Velcro fasteners,
and canes are all assistive devices.
Partnering with school staff to develop creative ways of dealing with JRA-caused limitations
can help your child make the best of his or her abilities.
Ongoing treatment
After your child's initial
treatment for
juvenile rheumatoid arthritis (JRA), it is likely that
he or she will require ongoing treatment throughout childhood. Many children
with JRA will outgrow their disease and lead normal adult lives, while others
will have some disability and will need continued treatment as adults. Physical
exercise and medicines will be the basics of treatment throughout the disease's
course.
Physical therapy is a vital component of the
successful ongoing management of JRA. Help your child understand the importance
of physical therapy exercises and help him or her keep an upbeat attitude about
twice-or-more daily stretching and strengthening sessions. Working closely with
a pediatric physical therapist can be especially helpful.
If your
child doesn't respond to
NSAID treatment (first-line treatment) after 2 or 3
months, additional medicine (second-line treatment) will be necessary to manage
symptoms and inflammation. Methotrexate has been found to be the most effective
second-line medicine for children with JRA.9 Children
who don't respond well to methotrexate can be offered similar medicines,
sometimes referred to as
disease-modifying antirheumatic drugs (DMARDs) or
slow-acting antirheumatic drugs (SAARDs).
Inflammatory eye disease can develop as a complication in children with JRA. Regular eye
examinations with an
ophthalmologist need to be included in your child's
treatment plan. Most children who develop eye disease are treated with
corticosteroids and prescription eyedrops called mydriatics. More severe or
continuing eye disease may require other medicines such as
methotrexate.9
Treatment if the condition gets worse
If your
child develops a severe type of
juvenile rheumatoid arthritis (JRA), your child's
treatment team will initiate treatments for more aggressive disease.
Physical therapy will be an important part of
treatment if your child is experiencing severe JRA. Regular physical exercise
will help maintain joint range and muscle strength and prevent
contractures. If your child is 4 years old or younger,
an adult will need to move the child's joints through the
range-of-motion exercises. Range-of-motion exercises
may be painful during a flare-up of arthritis, so it is very important to be
gentle. The
physical therapist can help set up an exercise program
for your child, either for the child to do alone or to do with help from an
adult. Exercises should be done every day and periodically reviewed by the
physical therapist.9 The therapist will be sure the
exercises are being done correctly and decide whether any exercises should be
added, dropped, or changed.
Combination therapy-using
methotrexate with other medicines such as sulfasalazine, hydroxychloroquine, or
etanercept-may be used to treat children with severe JRA.
Biological therapy is a new option to treat JRA, particularly
polyarticular JRA, that does not respond to other
treatments. The biological agent
etanercept, which is a tumor necrosis factor (TNF)
inhibitor, has had some success in relieving symptoms and decreasing the number
of flare-ups. Other TNF inhibitors, such as infliximab, are also used.10
Surgery may be used in a very small number of
children with JRA who have severe joint deformity, loss of movement, or pain.
Inflammatory eye disease can develop as a complication
in children with JRA. Regular eye examinations with an
ophthalmologist need to be included in your child's
treatment plan. Most children who develop eye disease are treated with
corticosteroids and prescription eyedrops called mydriatics. More severe or
continuing eye disease may require other medicines such as methotrexate. If eye
disease does not respond to these treatments, either, cyclosporine or TNF
inhibitors such as etanercept may help.9
What To Think About
Some children with JRA suffer a
loss of appetite severe enough that malnutrition becomes a medical concern. If
your child has little appetite for food, consult a nutritionist for help with
your child's basic nutritional needs.
Most children with JRA do
not go on to have adult rheumatoid arthritis or other long-term problems
related to JRA. Children with
pauciarticular JRA (4 or fewer affected joints) have a
good long-term outlook but an ongoing risk of developing eye disease. Children
with polyarticular JRA (5 or more joints) tend to have more problems
long-term.
Very few children with JRA have joint damage that
requires surgery. If at all possible, joint reconstruction is delayed until
childhood bone growth is complete (about 18 years of age).5
Prevention
Currently, the cause of
juvenile rheumatoid arthritis (JRA) is not well
understood, and there is no way to prevent it. The self-care methods listed
below may help prevent complications and make managing the illness
easier.
Preventing joint pain and swelling
Children with
JRA need a careful balance of activity and rest. Encourage your child not to
overdo activity when he or she is feeling well. Too much activity will
generally make soreness worse. Limit your child's participation in activities
that are stressful to joints (such as running or contact sports) during flares
of arthritis. But try not to discourage activity so that the child begins to
feel very different from his or her playmates or friends.
Be sure
that your child takes his or her medicine as prescribed. Use joint supports or
splints if your doctor recommends them. Apply heat to stiff and painful joints
for 20 minutes, repeating as needed. You can use hot water bottles, heating
pads on a low-to-medium setting, or hot packs, either towels dipped in warm
water or wet towels microwaved for 15 to 30 seconds. Do not leave a small child
unattended with a heating pad. Always make sure heating pads, hot water
bottles, and hot packs are not too hot for your child's skin.
Preventing morning stiffness
Many children with
JRA have less stiffness in the morning if their joints are kept warm during the
night. Footed pajamas or thermal underwear, or a sleeping bag, heated water
bed, or electric blanket may help keep joints warm.
Encourage your
child to take a warm bath or shower first thing in the morning to help ease
stiffness and then to stretch gently afterward.
Give morning
medicines as early as possible, with a snack or breakfast to prevent upsetting
an empty stomach.
Home Treatment
Living with
juvenile rheumatoid arthritis (JRA), a childhood
disease that causes inflamed, swollen joints, often means making lifestyle
changes and adjustments. This can be frustrating and demanding for you, your
child, and your family. But most children with JRA do not have long-term
disease and disability and go on to lead healthy adult lives. To help both you
and your child cope with the challenges of chronic illness, work as a team with
your child's doctors and other health professionals.
Home, school, and community activities
Regular
exercise, taking medicines, and using assistive devices when needed will help
your child function as normally as possible at home and school.
Range-of-motion exercises. Children with juvenile
rheumatoid arthritis (JRA) must do regular exercises to maintain joint range
and muscle strength and prevent
contractures. If you have an infant or child younger
than 4 years of age who has arthritis, an adult will need to move the child's
joints through the range-of-motion exercises. Older children can do the
exercises themselves but may still need adult supervision. Participation in
activities such as swimming or biking with other children helps improve a
child's ability to function, builds self-confidence, and may decrease pain and
disability.
Balancing rest and activity. Children
with JRA may need extra naps or quiet time during the day to rest their joints
and regain their strength. But long periods without activity can cause your
child's joints to be less flexible and may eventually lead to weakness in
unused muscles. It is also important not to overdo activity, particularly if it
causes pain or stiffness the following day.
Taking medicines. Sticking to a medication schedule can be difficult for
children with JRA. An older child may find it easier to remember to take
medicine by using a pillbox or chart for a day's or week's worth of medicine.
Ask your doctor whether the dose of medicine can be adjusted so your child can
take it at times that are most convenient and will not make him or her feel
"different." To avoid stomach upset, you can also give nonsteroidal
anti-inflammatory drugs (NSAIDs) with meals or a small snack.
Assistive devices. Items that can help
your child hold onto, open, close, move, or do things more easily include:
Doorknob extenders, to avoid twisting the
wrist to open doors.
Extended or enlarged handles on keys, pencils,
silverware, combs, or toothbrushes that make it easier to hold and use these
objects.
Lightweight clothing and toys.
Velcro
fasteners or simple, large fasteners on clothing, instead of small buttons or
snaps.
A large pull tab or a loop of cord on a zipper, to make
zipping clothing easier.
Elevated toilet seats, to avoid bending.
Canes or crutches, to assist walking.
Addressing school issues. Your child's
teachers, school nurse, cafeteria staff, and physical education teachers can
become helpful partners as your child copes with JRA at school. Work with them
to develop creative ways of dealing with your child's limitations and making
the best of his or her abilities. If your child has trouble walking distances,
see whether your child's classes can be scheduled to minimize walking and stair
climbing. If your child gets stiff sitting still during class, perhaps the
teacher can encourage him or her to wiggle around and stretch during the class.
If your child has trouble writing neatly, he or she might try using a larger
pencil or pen. Ask your child's physical or occupational therapist for other
ideas. Be sure to learn about your child's rights under the Individuals with
Disabilities Education Act (IDEA) and other federal and state laws regarding
the education of children with disabilities.
Inflammatory eye disease can develop as
a complication in children with JRA. Make sure your child has regular eye
examinations with an
ophthalmologist. The eye disease associated with JRA
often has no symptoms, although blurred vision may be an early symptom.
Children with disease in up to 4 joints (pauciarticular JRA) need the most frequent examinations.
Overall,
juvenile rheumatoid arthritis (JRA) has a good long-term outlook. The outlook
is even better when you and your child actively manage your child's health.
With greater understanding of the disease, you and your child will have less
fear, make better decisions, and have better results.
Take good physical care of yourself so that you can help your child
through the more difficult periods of illness. Consider becoming involved with
a support group of families who live with juvenile rheumatoid arthritis. Your
local chapter of the Arthritis Foundation can provide classes and support group
information.
Medications
Most children with
juvenile rheumatoid arthritis (JRA) need to take
medicine to reduce inflammation and control pain and to help prevent increasing
damage to the joints. When inflammation and pain are controlled, a child is
more willing and able to do joint exercises to improve joint strength and
prevent loss of movement.
Many different medicines are used to
treat JRA. No single medicine works for every child. It may take some time to
find the right medicine or combination of medicines that best controls your
child's symptoms. Treatment is individualized for each child by his or her
doctor and parents while considering effectiveness, side effects, cost, and the
type and severity of the disease.
Medication Choices
Although treatment varies depending on the needs of the
individual child, certain medications are often tried first (first-line
medications), while others are often saved to try later if they are needed
(second-line medications).
First-line medication. Nonsteroidal anti-inflammatory drugs (NSAIDs) are usually the first medicines tried to
control JRA inflammation and symptoms. Naproxen sodium is the most frequently
used NSAID treatment for JRA. Doctors choose naproxen based on its low
incidence of side effects compared to its effectiveness.9 Ibuprofen is an effective alternative. But in general, less
than one-third of children will have significant relief from NSAIDs.4
Corticosteroids may also be used as a first-line
medicine, especially as injections, for children who have
pauciarticular (oligoarthritis) with shortening of the
muscles around the joints (contractures). Oral or injected
corticosteroids are often used for
polyarticular disease with joint pain and swelling,
and sometimes intravenous (IV) corticosteroids are used for
systemic JRA.11
Second-line medication. If symptoms are not
well-controlled with NSAIDs or corticosteroids, stronger medicines such as
methotrexate are often used successfully.11
Methotrexate, sulfasalazine, and other second-line medications are sometimes
referred to as
disease-modifying antirheumatic drugs (DMARDs). Some
experts prefer to call them slow-acting antirheumatic drugs (SAARDs).
Some children with JRA gain significant benefit from early methotrexate
treatment. Although there is no definitive way of knowing which children are
the best candidates for early methotrexate treatment, this practice is becoming
more common in an effort to prevent joint and eye damage. Early treatment with
methotrexate is often used for polyarticular JRA.4
Biological therapy is a newer option to treat
JRA (particularly polyarticular JRA) that does not respond to other treatments.
The biological agent etanercept, which is a tumor necrosis factor (TNF)
inhibitor, has had some success in relieving symptoms and decreasing the number
of flare-ups. Other TNF inhibitors, such as infliximab, are also used.10
Antimalarials (such as hydroxychloroquine sulfate
[Plaquenil])
Adult therapies, such as cytotoxic (cell-destroying)
drugs and intravenous human immunoglobulin, that may be used for rheumatoid
arthritis in adults but are not yet proved to be safe and effective for
children with JRA
Gold salts were one of the first treatments used for
joint inflammation, and you may still hear about them. But injected gold salts
have been replaced by methotrexate for the treatment of JRA. Gold salts taken
by mouth (oral) have not been shown to be effective for JRA.9
Medications used to treat inflammatory eye disease
Mydriatics, which are eyedrops that dilate the pupil
and keep the iris from sticking to the cornea or lens
Tumor
necrosis factor (TNF) inhibitors. These medicines are biological agents known
as anti-TNF agents because they reduce inflammation by blocking the TNF
protein.
Etanercept is an example of these medicines.
What To Think About
Annual flu shots are recommended
for children who are on long-term aspirin therapy. Children on long-term
aspirin therapy who get
chickenpox or
influenza (flu) are at risk for getting Reye's
syndrome. Although there is a risk, Reye's syndrome is very rare. Very few
cases of Reye's syndrome have been reported in children with chronic arthritis
who were being treated with aspirin. If your child has been exposed to
chickenpox or flu, talk to the doctor about giving your child acetaminophen to
control pain and relieve fever until the incubation period, or the illness
itself, has passed.
Combination therapy-such as using methotrexate
with sulfasalazine, hydroxychloroquine, or etanercept-has been used on a
limited basis to treat JRA. Most medical experience with combination therapy is
with adults. Only children with severe JRA that has not improved with
methotrexate or sulfasalazine are considered for combination treatment.
It is impossible to predict whether a child will improve with a certain
medicine. Several different medicines may be tried before one is found that
controls symptoms and doesn't cause side effects. It can also take weeks to
months for a medicine to show effect, and symptoms may continue during that
time.
Surgery
Surgical treatment may be used in a very small
number of children with
juvenile rheumatoid arthritis (JRA) who have severe
joint deformity, loss of movement, or pain. Surgery is a possible treatment
option if your child has not improved with medicine and physical therapy and is
unable to walk or perform manual tasks.
Surgery Choices
When surgery to correct joint deformity is needed, the
more commonly used procedures include:
Soft tissue releases of contractures,
which involve cutting the muscles attached to an abnormally bent joint. As the
muscles and other shortened tissues are released, the affected joint can return
to a more normal position.
Total joint replacement, which may be considered as a last resort for joints that
have been so badly damaged by JRA that walking is very difficult or impossible.
Important considerations for you to think about
include your child's age, the number of joints involved in the disease, and the
impact on your child's mobility.
Other surgical procedures that have been used in children
with JRA but are recommended only in selected cases include:
Osteotomy, which
involves removing a wedge of bone to allow more normal alignment of the joint.
An osteotomy may be recommended for children who have severe joint
contractures.
Epiphysiodesis,
in which the portion in a long leg bone where growth occurs is removed in order
to stop growth.
Synovectomy or tenosynovectomy, rarely used for JRA. Synovectomy involves the surgical
removal of the joint lining (synovium) and/or the covering of the tendon
(tenosynovectomy) to reduce joint inflammation.
Arthrodesis, rarely used in children, which involves
the fusion of two bones in a diseased joint so that the joint can no longer
move.
What To Think About
The main things to think about
for surgery during childhood are the child's age and whether his or her bones
are still growing. When considering total joint replacement, it is also
important to consider the possibility of needing another joint replacement in
10 to 20 years. The timing often requires a balance between the child's age,
the expected life of the replaced joint, and the possible loss of bone and
muscle strength if surgery is delayed too long.
Other Treatment
Physical and
occupational therapy are vital to the successful
management of
juvenile rheumatoid arthritis (JRA). Maintaining good
joint function and range of motion and being able to do daily tasks help a
child who has JRA develop normally.
Other Treatment Choices
Physical and occupational therapy
The purpose of
physical therapy is to decrease pain and increase strength and range of motion,
to allow your child to resume or continue normal activities. Occupational
therapy works to help a child live as independently as possible.
Physical conditioning may include aerobic
exercise, range-of-motion exercises, and strength and stretching
exercises.
Splinting at night will help keep the
wrist, hand, knee, and/or ankle joints straight, which may prevent pain,
morning stiffness, and contractures. Working splints can help support a joint
and relieve pain when writing or doing other hand tasks.
Serial casting of the knees, ankles, wrists, fingers, and/or elbows is a
temporary straightening and casting of the affected joint. The cast is then
removed, the child goes through some physical therapy, and a new cast is
applied with the joint stretched a bit more.
Shoe lifts or inserts help to equalize leg lengths for children in whom one
leg grows at a different rate than the other.
Nutrition
Healthy eating means eating a variety
of foods so that your child gets the nutrients he or she needs for growth and
development. Good nutrition will also help fight the effects of JRA. Important
nutrients include protein, carbohydrate, fat, vitamins, and minerals. Your
child can eat all types of food as long as his or her weekly intake is balanced
and varied.
As part of a healthy diet for a child with
JRA, your child's doctor may recommend
vitamin D and calcium. These nutrients can help
control bone loss that is often linked with inactivity and with corticosteroid
treatment.
Some nutrients are thought to help reduce inflammation,
so they may help decrease some symptoms of JRA.
Vitamin C is an antioxidant that may help
reduce inflammation in the body. Vitamin C is found in citrus fruits, tomatoes,
berries, broccoli, cabbage, and brussels sprouts.
Omega-3 fatty
acids in fish oil have been shown to mildly reduce inflammation in adults with
rheumatoid arthritis and may have the same effect in children with JRA. The
best sources of omega-3 fatty acids are cold-water fish and flaxseed
oil.12
Complementary medicine therapies for pain management
Massage is used to promote relaxation,
relieve pain, and restore normal joint movement.
Guided imagery may be used to promote relaxation and manage
pain.
Acupuncture is mildly effective in relieving pain in
adults who have rheumatoid arthritis and may help relieve pain in children who
have JRA.
What To Think About
Physical therapy is a vital
component of the successful management of juvenile rheumatoid arthritis. If
possible (depending on age), help your child to understand the importance of
physical therapy exercises and to keep an upbeat attitude about twice-or-more
daily stretching and strengthening sessions. Working closely with a pediatric
physical therapist can be especially helpful.
Other Places To Get Help
Organizations
American Academy of Orthopaedic Surgeons
(AAOS)
6300 North River Road
Rosemont, IL 60018-4262
Phone:
1-800-346-AAOS (1-800-346-2267) (847) 823-7186
Fax:
(847) 823-8125
E-mail:
pemr@aaos.org
Web Address:
www.aaos.org
The American Academy of Orthopaedic Surgeons (AAOS) provides
information and education to raise the public's awareness of musculoskeletal
conditions, with an emphasis on preventive measures. The AAOS Web site contains
information on orthopedic conditions and treatments, injury prevention, and
wellness and exercise.
American College of Rheumatology
1800 Century Place
Suite 250
Atlanta, GA 30345
Phone:
(404) 633-3777
Fax:
(404) 633-1870
Web Address:
www.rheumatology.org
The American College of Rheumatology (ACR) and the
Association of Rheumatology Health Professionals (ARHP, a division of ACR) are
professional organizations of rheumatologists and associated health
professionals who are dedicated to healing, preventing disability from, and
curing the many types of arthritis and related disabling and sometimes fatal
disorders of the joints, muscles, and bones. Members of the ACR are physicians;
members of the ARHP include research scientists, nurses, physical and
occupational therapists, psychologists, and social workers. Both the ACR and
the ARHP provide professional education for their members.
The ACR
Web site offers patient information fact sheets about rheumatic diseases, about
medicines used to treat rheumatic diseases, and about care
professionals.
Juvenile Arthritis Alliance (JA
Alliance)
P.O. Box 7669
Atlanta, GA 30357-0669
Phone:
1-800-283-7800
Web Address:
www.arthritis.org/ja-alliance-main.php
The Juvenile Arthritis Alliance (JA Alliance or JAA) is
a virtual community connected through the Arthritis Foundation Web site. Its
members are parents, volunteers, health professionals, and anyone who is
affected by juvenile arthritis. The JAA works to reach children and families
with developmentally appropriate quality programs and services. Such programs
and services include national and regional JA conferences, juvenile arthritis
camps, evidence-based JA programs, and chapter level informational workshops
(family days that focus on children and youth newly diagnosed with arthritis
and on their families). The JAA Web site includes information on juvenile
arthritis issues such as treatment and dealing with juvenile arthritis in
everyday life. The Web site also offers information on networking, advocacy,
and research.
Kids on the Block
9385-C Gerwig Lane
Columbia, MD 21046-1583
Phone:
1-800-368-KIDS (1-800-368-5437) (410) 290-9095
Fax:
(410) 290-9358
E-mail:
kob@kotb.com
Web Address:
www.kotb.com
Kids on the Block features life-size puppets in
educational programs that enlighten children and adults on the issues of
disability awareness, medical and educational differences, and social concerns.
Kids on the Block has a strong commitment to providing communities with
programs that address children's questions, concerns, and needs in a lively and
entertaining manner. Curricula are developed for juvenile rheumatoid arthritis,
asthma, brain injury, and many other topics. Most programs are designed for
school-aged children and are interactive during live presentations. An Early
Learning Series for children ages 3 to 6 is available on video.
National Institute of Arthritis and Musculoskeletal and
Skin Diseases (NIAMS), National Institutes of Health
The National Institute of Arthritis and Musculoskeletal
and Skin Diseases (NIAMS) is a governmental institute that serves the public
and health professionals by providing information, locating other information
sources, and participating in a national federal database of health
information. NIAMS supports research into the causes, treatment, and prevention
of arthritis and musculoskeletal and skin diseases and supports the training of
scientists to carry out this research.
The NIAMS Web site provides
health information referrals to the NIAMS Clearinghouse, which has information
packages about diseases.
References
Citations
Prahalad S, et al. (2002). Increased prevalence of
familial autoimmunity in simplex and multiplex families with juvenile
rheumatoid arthritis. Arthritis and Rheumatism, 46(7):
1851-1856.
Anthony KK, Schanberg LE (2003). Pain in children with
arthritis: A review of the current literature. Arthritis and Rheumatism, 49(2): 272-279.
Labyak SE, et al. (2003). Sleep quality in children
with juvenile rheumatoid arthritis. Holistic Nursing Practice, 17(4): 193-200.
Hashkes PJ, Laxer RM (2005). Medical treatment of
juvenile ideopathic arthritis. JAMA, 294(13):
1671-1684.
Cassidy JT (2005). Juvenile rheumatoid arthritis. In
ED Harris Jr et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1579-1596. Philadelphia: Elsevier
Saunders.
Warren RW, et al. (2005). Juvenile idiopathic
arthritis (Juvenile rheumatoid arthritis). In WJ Koopman, LW Moreland, eds.,
Arthritis and Allied Conditions, 15th ed., vol. 1, pp.
1277-1300. Philadelphia: Lippincott Williams and Wilkins.
Wallace CA, Sherry DD (2003). Juvenile rheumatoid
arthritis. In CD Rudolph et al., eds., Rudolph's Pediatrics, 21st ed., chap 12.4, pp. 836-840. New York: McGraw-Hill.
Simon L, et al. (2002). Treatment of pain in children
and older adults with arthritis. In Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis, 2nd ed., chap. 5, pp. 119-129. Glenview, IL: American
Pain Society.
Giannini EH, Brunner HI (2005). Treatment of juvenile
rheumatoid arthritis. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions, 15th ed., vol. 1, pp.
1301-1318. Philadelphia: Lippincott Williams and Wilkins.
Hollister JR (2007). Rheumatic diseases. In WW Hay Jr
et al., eds., Current Pediatric Diagnosis and Treatment,
18th ed., chap. 26, pp. 822-829. New York: McGraw-Hill.
Miller ML, Cassidy JT (2007). Juvenile rheumatoid
arthritis. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., chap. 154, pp. 1001-1011. Philadelphia:
Saunders.
Murray MT, Pizzorno JE Jr (2006). Rheumatoid
arthritis. In JE Pizzorno, MT Murray, eds., Textbook of Natural Medicine, 3rd ed., vol. 2, pp. 2089-2108. St. Louis:
Churchill Livingstone Elsevier.
Other Works Consulted
Pisetsky DS, St Clair EW (2001). Progress in the
treatment of rheumatoid arthritis. JAMA, 286(22):
2787-2790.
Van der Linden S, van der Heijde D (1998). Ankylosing
spondylitis: Clinical features. Rheumatic Disease Clinics of North America, 24(4): 663-676.
Wilson D, et al. (2007). Juvenile rheumatoid arthritis
(juvenile idiopathic arthritis) section of The child with musculoskeletal or
articular dysfunction. In Wong's Nursing Care of Infants and Children, 8th ed., chap. 39, pp. 1791-1798. St. Louis: Mosby
Elsevier.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Prahalad S, et al. (2002). Increased prevalence of
familial autoimmunity in simplex and multiplex families with juvenile
rheumatoid arthritis. Arthritis and Rheumatism, 46(7):
1851-1856.
Anthony KK, Schanberg LE (2003). Pain in children with
arthritis: A review of the current literature. Arthritis and Rheumatism, 49(2): 272-279.
Labyak SE, et al. (2003). Sleep quality in children
with juvenile rheumatoid arthritis. Holistic Nursing Practice, 17(4): 193-200.
Hashkes PJ, Laxer RM (2005). Medical treatment of
juvenile ideopathic arthritis. JAMA, 294(13):
1671-1684.
Cassidy JT (2005). Juvenile rheumatoid arthritis. In
ED Harris Jr et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1579-1596. Philadelphia: Elsevier
Saunders.
Warren RW, et al. (2005). Juvenile idiopathic
arthritis (Juvenile rheumatoid arthritis). In WJ Koopman, LW Moreland, eds.,
Arthritis and Allied Conditions, 15th ed., vol. 1, pp.
1277-1300. Philadelphia: Lippincott Williams and Wilkins.
Wallace CA, Sherry DD (2003). Juvenile rheumatoid
arthritis. In CD Rudolph et al., eds., Rudolph's Pediatrics, 21st ed., chap 12.4, pp. 836-840. New York: McGraw-Hill.
Simon L, et al. (2002). Treatment of pain in children
and older adults with arthritis. In Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis, 2nd ed., chap. 5, pp. 119-129. Glenview, IL: American
Pain Society.
Giannini EH, Brunner HI (2005). Treatment of juvenile
rheumatoid arthritis. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions, 15th ed., vol. 1, pp.
1301-1318. Philadelphia: Lippincott Williams and Wilkins.
Hollister JR (2007). Rheumatic diseases. In WW Hay Jr
et al., eds., Current Pediatric Diagnosis and Treatment,
18th ed., chap. 26, pp. 822-829. New York: McGraw-Hill.
Miller ML, Cassidy JT (2007). Juvenile rheumatoid
arthritis. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., chap. 154, pp. 1001-1011. Philadelphia:
Saunders.
Murray MT, Pizzorno JE Jr (2006). Rheumatoid
arthritis. In JE Pizzorno, MT Murray, eds., Textbook of Natural Medicine, 3rd ed., vol. 2, pp. 2089-2108. St. Louis:
Churchill Livingstone Elsevier.